Squarepoint
MRK icon

Squarepoint’s Merck MRK Stock Holding History

Squarepoint’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3M Sell
118,900
-15,400
-11% -$1.78M 0.02% 884
2025
Q4 		$14.1M Sell
134,300
-286,600
-68% -$26.9M 0.02% 909
2025
Q3 		$35.3M Sell
420,900
-306,600
-42% -$25.3M 0.04% 523
2025
Q2 		$57.6M Sell
727,500
-245,500
-25% -$19.5M 0.06% 353
2025
Q1 		$87.3M Buy
973,000
+819,900
+536% +$76.6M 0.11% 185
2024
Q4 		$15.2M Sell
153,100
-83,300
-35% -$8.59M 0.02% 904
2024
Q3 		$26.8M Buy
236,400
+152,900
+183% +$18.2M 0.04% 470
2024
Q2 		$10.3M Sell
83,500
-84,100
-50% -$10.8M 0.02% 928
2024
Q1 		$22.1M Buy
167,600
+59,600
+55% +$7.35M 0.04% 572
2023
Q4 		$11.8M Sell
108,000
-59,200
-35% -$6.15M 0.02% 844
2023
Q3 		$17.2M Buy
167,200
+119,200
+248% +$12.8M 0.04% 527
2023
Q2 		$5.54M Buy
48,000
+45,800
+2,082% +$5.2M 0.02% 1020
2023
Q1 		$234K Sell
2,200
-53,600
-96% -$5.79M ﹤0.01% 2714
2022
Q4 		$6.19M Sell
55,800
-9,100
-14% -$930K 0.02% 731
2022
Q3 		$5.59M Sell
64,900
-102,300
-61% -$9.13M 0.03% 694
2022
Q2 		$15.2M Sell
167,200
-127,600
-43% -$11.3M 0.08% 268
2022
Q1 		$24.2M Buy
294,800
+234,400
+388% +$18.5M 0.1% 199
2021
Q4 		$4.63M Buy
60,400
+4,600
+8% +$366K 0.01% 828
2021
Q3 		$4.19M Buy
55,800
+37,400
+203% +$2.84M 0.01% 858
2021
Q2 		$1.43M Sell
18,400
-9,686
-34% -$720K 0.01% 1382
2021
Q1 		$2.07M Buy
28,086
+17,606
+168% +$1.3M 0.01% 1050
2020
Q4 		$818K Buy
10,480
+7,022
+203% +$537K 0.01% 1464
2020
Q3 		$274K Buy
3,458
+628
+22% +$49.2K ﹤0.01% 1868
2020
Q2 		$209K Buy
+2,830
New +$213K ﹤0.01% 1809
2020
Q1 		– Sell
-5,030
Closed -$437K – 2278
2019
Q4 		$437K Buy
+5,030
New +$413K ﹤0.01% 1846

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Squarepoint's MRK Position: Q1 2026 in Review

Squarepoint increased its Merck (MRK) stake by 1,156% in Q1 2026, buying an estimated $88.3M and bringing the position to 830,857 shares worth $99.9M. The position accounts for 0.12% of the portfolio, ranked #165.

Squarepoint first reported a position in MRK in Q4 2014 and has held it in 37 quarters since. The position peaked at $348M in Q1 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Squarepoint held 830,857 shares of Merck worth $99.9M as of Q1 2026.
  • Squarepoint bought 764,712 Merck shares in Q1 2026, an estimated $88.3M.
  • Merck made up 0.12% of Squarepoint's portfolio in Q1 2026, its #165 holding.
  • Squarepoint first reported a position in Merck in Q4 2014 and has held it in 37 quarters since.
  • Squarepoint's Merck position peaked at $348M in Q1 2025.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.